Skip to search formSkip to main contentSkip to account menu

Vepesid

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Drugs with low water solubility are predisposed to low and variable oral bioavailability and, therefore, to variability in… 
Review
2006
Review
2006
Features of temozolomideTemozolomide (TMZ) belongs to the imidazotetrazine class and it is a DNA-methylating agent that has a… 
Highly Cited
2004
Highly Cited
2004
PURPOSE To evaluate the efficacy and toxicity of the sequential administration of paclitaxel (Taxol; Bristol-Myers Squibb… 
2004
2004
Inhibition of DNA topoisomerase II with vepesid induced structural and functional reorganization of chromatin in meiotically… 
Highly Cited
1999
Highly Cited
1999
The objective of this study was to accurately determine the within- and between-patient variability in etoposide pharmacokinetics… 
Highly Cited
1991
Highly Cited
1991
We have shown previously a good correlation between etoposide-induced sister chromatid exchanges (SCE) and cytotoxicity. A… 
1990
1990
The objective of this trial was to define the antitumor activity and toxicity of etoposide for second-line treatment of patients… 
Review
1985
Review
1985
Cisplatin (Platinol)-containing regimens, especially in combination with etoposide (VP-16) (VePesid), vindesine, and/or mitomycin… 
Highly Cited
1985
Highly Cited
1985
The absolute oral bioavailability of etoposide (VePesid) was determined in cancer patients based on a comparison of intravenous…